---
title: 'Manufacturing Daily Summary: What Happened on October 22, 2026'
headline: Invitris is developing cell-free production of proteins and phages
description: The company says its platform can turn digital sequences into proteins
in hours without growing production cells.
url: https://thebench.bio/news/manufacturing/2026-10-22
topic: manufacturing
date: '2026-10-22'
covers:
- '2026-10-22'
date_published: '2026-10-22T12:01:42Z'
date_modified: '2026-10-22T12:01:42Z'
tags:
- Manufacturing
sources: 1
publisher: TheBench.Bio
---
# Manufacturing Daily Summary: What Happened on October 22, 2026
**Invitris is developing cell-free production of proteins and phages**
The company says its platform can turn digital sequences into proteins in hours without growing production cells.
## Today in brief
Invitris says its Phactory platform makes proteins, antibodies and functional phages from digital sequences in four to eight hours, without cultivating production cells. [1] The company is also exploring whether microgravity could help produce larger biological structures through the SPRIND Orbital Bioworks Challenge. [1]
## A cell-free route to biological products
Invitris says Phactory can produce proteins, antibodies and functional phages from digital sequences in four to eight hours, without growing production cells. [1] The company is exploring the platform’s potential in microgravity through the SPRIND Orbital Bioworks Challenge. [1]
## The day in numbers
- **Four to eight hours**: Time Invitris says its platform takes to turn a digital sequence into proteins. [1]
## Sources
1. [Closing AI medicine’s manufacturing gap](), European Biotechnology, 2026-10-22
---
TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.
[1]: